Answers are grounded in this paper and cite their sources.
Background Urinary tract infections (UTIs) remain among the most prevalent bacterial infections encountered in clinical practice, and their global burden has risen substantially over recent decades. Recurrent and complicated UTIs disproportionately affect specific populations—including women, older adults, patients with diabetes, pregnant individuals, and those with structural, functional, or healthcare-associated risk factors—and are increasingly complicated by antimicrobial resistance. Although recurrent pyelonephritis has long been implicated in renal parenchymal injury and scarring, the extent to which infection itself, as opposed to underlying host or anatomical vulnerability, drives progression to hypertension and chronic kidney disease (CKD) remains incompletely resolved. Objective This narrative review synthesises contemporary evidence on the epidemiology and classification of recurrent and complicated UTI, the populations at greatest risk, the mechanisms underlying antimicrobial resistance among uropathogens, the pathophysiological pathway linking recurrent pyelonephritis to renal injury, and the evidence connecting recurrent or complicated infection to long-term kidney outcomes. Methods Contemporary literature (2021–2026), together with foundational earlier studies, guideline recommendations from IDSA, EAU, AUA, KDIGO, and related bodies, and relevant systematic reviews and cohort studies, were critically appraised and integrated into a mechanistic and clinically oriented synthesis. Summary of evidence Renal injury during pyelonephritis appears to be driven predominantly by the host inflammatory response rather than bacterial virulence alone, with cumulative febrile episodes associated with a stepwise increase in scarring risk. However, population-based cohorts demonstrate a marked dissociation between the frequency of radiologically detected scarring and the infrequency of progression to hypertension, CKD, or end-stage renal disease, suggesting that pre-existing congenital or anatomical vulnerability—rather than infection burden alone—is a major determinant of long-term outcome. Evidence supporting culture-directed stewardship and correction of structural abnormalities is more robust than evidence directly linking infection-control measures to preserved long-term renal function.
No takes yet. Share an insight, caveat, or question.
Hassan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: